Meet an Unreasonable Venture
CyanoCapture
Bringing affordable carbon capture to emitting industries worldwide.
Over 27% of the FDA's list of essential drugs were categorised as 'at risk'. CyanoCapture's photosynthetic biomanufacturing platform makes it possible to synthesise $40bn worth of drug molecules in short supply, affordably for customers around the world. The technology uses cutting-edge ML tools, genomic and transcriptomic datasets to genetically programme fast-growing photosynthetic cells to secrete drug molecules designed by the user.
Notable Achievements
- Raised $4.49M in equity financing from VCs and angels and a further $5M in non-dilutive prizes.
- Secured $27m in LOIs and pre-orders.
- Winner - Elon Musk's XPRIZE 2021.
Currently Operating in One Region
More Ventures in Energy & Environment
Get the Unreasonable Newsletter
Get monthly updates on CyanoCapture and all of the other ventures working to solve global challenges.